Asia Pacific Colorectal Cancer Diagnostics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 530,001.39 Thousand |
 Market Size (Forecast Year) |
USD 1,056,573.99 Thousand |
 CAGR |
% |
| Major Markets Players |
亚太结直肠癌诊断市场，按测试类型（粪便检查、影像学检查、活检、血液检查等）、产品类型（仪器和试剂盒及试剂）、癌症分期（0 期、I 期、II 期、III 期和 IV 期）、癌症类型（腺癌、结直肠淋巴瘤、胃肠道间质瘤、类癌瘤、平滑肌肉瘤、黑色素瘤等）、年龄组（老年、成人和儿童）、最终用户（医院、诊断中心、癌症研究中心、门诊手术中心、学术机构等）、分销渠道（直接招标、零售和在线销售）划分 - 行业趋势和预测到 2030 年。
亚太地区结直肠癌诊断市场分析与洞察
亚太地区对结直肠癌的认识不断提高，这增强了市场需求。为获得更好的医疗服务而增加的医疗支出也促进了市场的增长。在这一关键时期，主要市场参与者专注于各种服务的推出和批准。此外，诊断过程和技术的改进也促进了结直肠癌诊断测试需求的增加。
亚太地区结直肠癌诊断市场预计将在 2023 年至 2030 年的预测期内增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场将以 9.0% 的复合年增长率增长，预计到 2030 年将从 2022 年的 530,001.39 万美元增至 1,056,573.99 万美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（千美元） |
|
涵盖的领域 |
检测类型（粪便检查、影像学检查、活检、血液检查等）、产品类型（仪器和试剂盒及试剂）、癌症分期（0 期、I 期、II 期、III 期和 IV 期）、癌症类型（腺癌、结直肠淋巴瘤、胃肠道间质瘤、类癌瘤、平滑肌肉瘤、黑色素瘤等）、年龄组（老年、成人和儿童）、最终用户（医院、诊断中心、癌症研究中心、门诊手术中心、学术机构等）、分销渠道（直接招标、零售和在线销售） |
|
覆盖国家 |
中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、越南和亚太地区其他地区 |
|
涵盖的市场参与者 |
F. Hoffmann-La Roche Ltd.（瑞士）、Illumina, Inc.（美国）、QIAGEN（美国）、Thermo Fisher Scientific Inc.（美国）、Quest Diagnostics Incorporated, Inc.（美国）、Siemens Healthcare GmbH（德国）、Myriad Genetics, Inc.（美国）、Koninklijke Philips NV（荷兰）、FUJIFILM Corporation（日本）、CANON MEDICAL SYSTEMS CORPORATION（日本）、Bio-Rad Laboratories, Inc.（美国）、东软集团（中国）、Exact Sciences Corporation（美国）、bioMérieux SA（法国）、Sysmex Asia Pacific Pte Ltd（新加坡）、GE HealthCare（美国）、Medtronic（爱尔兰）和安捷伦科技公司（美国）等。 |
亚太地区结直肠癌诊断市场的市场定义
结直肠癌起源于结肠或直肠。根据其起源部位，这些癌症也可以称为结肠癌或直肠癌。结肠癌和直肠癌通常被归为一类，因为它们具有许多共同特征。结直肠癌是一种结肠或直肠细胞失控生长的疾病。有时它被简称为结肠癌。结肠是大肠或大肠。直肠是连接结肠和肛门的通道。
由于市场参与者的增加和先进服务的可用性，预计亚太地区结直肠癌诊断市场将在预测年内增长。与此同时，制造商正致力于研发活动，以在市场上推出新服务。结直肠癌诊断和开发领域的研究不断增加，进一步推动了市场的增长。然而，结直肠癌筛查技术的困难可能会阻碍预测期内亚太地区结直肠癌诊断市场的增长。
亚太地区结直肠癌诊断市场动态
本节旨在了解市场驱动因素、优势、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 结直肠癌患病率增长
大肠是结肠癌最先出现的地方（结肠）。消化系统以结肠结束。结肠癌可以袭击任何年龄的任何人，但通常袭击老年人。小的良性（非癌性）细胞簇称为息肉，通常生长在结肠内部，这是该病的最初迹象。其中一些息肉最终可能发展成结肠癌。
由于各种风险因素，该地区结直肠癌发病率不断上升，已成为一个重大的社会经济问题。预计这将成为亚太地区结直肠癌诊断市场增长的推动力。
- 预防性健康检查的偏好日益增加
预防性健康检查是为了初步发现癌症而采取的预防措施，而且预防性健康检查的日益流行为将来可能接触任何疾病提供了保障。
提高筛查意识是预防癌症最重要的组成部分。筛查包括识别癌症和检查风险因素，以在早期阶段限制损失。
预防性癌症检查是通过各种诊断测试进行的，包括超声波、活检、免疫组织化学、结肠直肠抗体测试和血液测试（TSH、T3 和 T4、TSI）等。
克制
- 严格的监管政策
药品监管在医疗保健领域发挥着重要作用。在这些司法管辖区内，获得合法销售医疗器械或药品的必要批准可能需要大量的财务支出，而且可能需要数月或数年才能完成。如果不了解或不考虑这些限制，延误可能会严重危及在竞争激烈的市场中取得成功的可能性。疫苗、血液和血液成分、过敏原、体细胞、基因治疗、组织和重组治疗蛋白等生物制剂对治疗各种疾病具有重要意义。但它们在全球多个地区的批准和营销需要满足严格的监管标准并获得各监管机构的认可。
机会
- 对非侵入性检测方法的需求增加
结直肠癌诊断中对非侵入性检测方法的需求不断增长，为亚太地区结直肠癌诊断市场带来了良好的机遇。非侵入性检测为结肠镜检查等侵入性检查提供了一种有吸引力的替代方案，因为它们对患者更友好、更少威胁，而且通常不需要麻醉或专门的设施。这吸引了那些可能不愿意接受传统筛查的人，从而扩大了市场，增加了患者对定期筛查的参与度。通过非侵入性检测早期发现结直肠癌可以显著改善患者的治疗效果，从而实现及时治疗干预，并可能提高存活率。此外，这些检测非常适合偏远和服务不足的地区，因为它们可以在初级保健环境中轻松进行，解决了可及性挑战并促进了医疗保健公平。随着公共卫生计划的不断增加和非侵入性诊断技术的不断进步，亚太地区结直肠癌诊断市场有望在加强该地区结直肠癌的早期发现、患者依从性和整体管理方面发挥重要作用。
- 市场参与者的战略举措
各种癌症的发病率及其严重程度在人群中普遍增加。研究质量的大幅提高以及研究机会的增加是由于市场参与者采取了各种战略举措。多年来，他们采取了产品发布、合作、合并、收购等举措，预计将引领并创造更多市场机会。
结直肠癌诊断市场主要公司进行的这些战略性产品发布、收购和合并为各个地区的公司开辟了机会。这些战略使公司能够加强其在市场上的影响力。因此，据预测，战略举措是市场参与者加速其市场收入增长的黄金机会。
挑战
- 结肠直肠癌诊断较晚且预后不良
晚期结直肠癌诊断是疾病管理中的一大挑战。当晚期结直肠癌被诊断出来时，治疗变得更加复杂，成功率也降低了。延迟诊断往往会导致癌症扩散到附近的组织或远处的器官，使其更难以进行治愈干预。这给制定有效的治疗计划带来了挑战，增加了并发症的风险，并可能限制可用的治疗方案。此外，晚期结直肠癌可能导致患者预后较差、生活质量下降和医疗费用增加。
最新动态
- 2022 年 8 月，罗氏公司宣布推出数字 LightCycler 系统，这是罗氏的首款数字聚合酶链反应 (PCR) 系统。这款新一代系统可检测疾病，旨在准确量化传统 PCR 方法通常无法检测到的微量特定 DNA 和 RNA 靶标。这有助于该公司扩大其在亚太市场的影响力。
亚太地区结直肠癌诊断市场范围
亚太地区结直肠癌诊断市场细分为检测类型、产品类型、癌症阶段、年龄组、癌症类型、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
测试类型
- 粪便检查
- 验血
- 影像检查
- 活检
- 其他的
根据测试类型，亚太地区结直肠癌诊断市场分为粪便检查、影像学测试、血液测试、活检等。
产品类型
- 仪器
- 试剂盒和试剂
根据产品类型，亚太地区结直肠癌诊断市场分为仪器、试剂盒和试剂。
癌症类型
- 腺癌
- 结直肠淋巴瘤
- 胃肠道间质瘤
- 类癌肿瘤
- 平滑肌肉瘤
- 黑色素瘤
- 其他的
根据癌症类型，亚太地区结直肠癌诊断市场分为腺癌、结直肠淋巴瘤、胃肠道间质瘤、类癌瘤、平滑肌肉瘤、黑色素瘤等。
癌症分期
- 第三阶段
- 第四阶段
- 第二阶段
- 第一阶段
- 第 0 阶段
根据分期，亚太地区结直肠癌诊断市场分为 0 期、I 期、II 期、III 期和 IV 期。
年龄组
- 老年
- 成年人
- 儿科
根据年龄组，亚太地区结直肠癌诊断市场分为老年人、成年人和儿童。
最终用户
- 医院
- 诊断中心
- 癌症研究中心
- 门诊手术中心
- 学术机构
- 其他的
根据最终用户，亚太地区结直肠癌诊断市场分为医院、诊断中心、癌症研究中心、门诊手术中心、学术机构等。
分销渠道
- 直接招标
- 零售销售
- 网上销售
根据分销渠道，亚太地区结直肠癌诊断市场分为直接招标、零售和在线销售。
亚太地区结直肠癌诊断市场区域分析/见解
对亚太地区结直肠癌诊断市场进行了分析，并按国家、产品类型、测试类型、癌症类型、癌症阶段、年龄组、最终用户和分销渠道提供了市场规模洞察和趋势。
本市场报告涵盖的国家包括日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、越南和亚太其他地区
预计中国将在市场份额和收入方面主导亚太地区结直肠癌诊断市场，并将在预测期内继续保持主导地位。这是由于人们对预防性健康检查的偏好日益增加。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的竞争而面临的挑战以及销售渠道的影响。
竞争格局和亚太地区结直肠癌诊断市场份额分析
结直肠癌诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对结直肠癌诊断市场的关注有关。
亚太地区结直肠癌诊断市场的一些主要参与者包括 F. Hoffmann-La Roche Ltd.（瑞士）、Illumina, Inc.（美国）、QIAGEN（美国）、Thermo Fisher Scientific Inc.（美国）、Quest Diagnostics Incorporated, Inc.（美国）、Siemens Healthcare GmbH（德国）、Myriad Genetics, Inc.（美国）、Koninklijke Philips NV（荷兰）、FUJIFILM Corporation（日本）、CANON MEDICAL SYSTEMS CORPORATION（日本）、Bio-Rad Laboratories, Inc.（美国）、东软集团（中国）、Exact Sciences Corporation（美国）、bioMérieux SA（法国）、Sysmex Asia Pacific Pte Ltd（新加坡）、GE HealthCare（美国）、Medtronic（爱尔兰）和 Agilent Technologies, Inc.（美国）等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL'S MODEL
4.2 PORTER'S 5 FORCES
4.3 LIST OF DISTRIBUTORS
5 HEALTHCARE ECONOMY
5.1 HEALTHCARE EXPENDITURE
5.2 CAPITAL EXPENDITURE
5.3 CAPEX TRENDS
5.4 CAPEX ALLOCATIONS
5.5 FUNDING SOURCES
5.6 INDUSTRY BENCHMARKS
5.7 GDP RATIO IN OVERALL GDP
5.8 HEALTHCARE SYSTEM STRUCTURE
5.9 GOVERNMENT POLICIES
5.1 ECONOMIC DEVELOPMENT
6 INDUSTRY INSIGHTS
6.1 MACRO AND MICRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
7 REIMBURSEMENT SCENARIO
8 STRATEGIC ANALYSIS
8.1 JOINT VENTURES
8.2 MERGERS AND ACQUISITIONS
8.3 LICENSING AND PARTNERSHIP
8.4 TECHNOLOGY COLLABORATIONS
9 TECHNOLOGY ROADMAP
10 VALUE CHAIN ANALYSIS
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO
11.6 REGULATORY CHALLENGES AND STRATEGY
11.6.1 REGULATORY SCENARIO IN AUSTRALIA
11.6.2 REGULATORY SCENARIO IN JAPAN
11.6.3 REGULATORY SCENARIO IN CHINA
11.6.4 REGULATORY SCENARIO IN INDIA
12 MARKET OVERVIEW
12.1 DRIVERS
12.1.1 GROWING PREVALENCE OF COLORECTAL CANCER
12.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS
12.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
12.2 RESTRAINTS
12.2.1 STRINGENT REGULATORY POLICIES
12.2.2 HIGH COST FOR COLORECTAL CANCER DIAGNOSIS
12.3 OPPORTUNITIES
12.3.1 INCREASED DEMAND FOR NON-INVASIVE TESTING METHODS
12.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
12.4 CHALLENGES
12.4.1 LATE COLORECTAL CANCER DIAGNOSIS AND POOR PROGNOSIS
12.4.2 HIGH FALSE POSITIVES AND POOR SENSITIVITY OF CANCER DIAGNOSIS
13 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE
13.1 OVERVIEW
13.2 STOOL EXAMINATION
13.2.1 FECAL OCCULT BLOOD TEST (FOBT)
13.2.1.1 GUAIAC FECAL OCCULT BLOOD TEST (FOBT)
13.2.1.2 IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST (FOBT)
13.2.2 FECAL IMMUNOCHEMICAL TEST (FIT)
13.2.3 STOOL DNA TESTING
13.3 BLOOD TEST
13.3.1 COMPLETE BLOOD COUNT (CBC)
13.3.2 TUMOR MARKER TEST
13.3.2.1 CARCINOEMBRYONIC ANTIGEN (CEA)
13.3.2.2 CA19-9 BIOMARKER TEST
13.3.2.3 HER2 PROTEIN
13.3.2.4 MSI AND MMR TESTING
13.3.2.5 CA 50 MARKER TEST
13.3.2.6 KRAS, NRAS, AND BRAF GENES
13.3.2.7 OTHERS
13.3.3 LIVER ENZYME BLOOD TEST
13.4 IMAGING TEST
13.4.1 COMPUTED TOMOGRAPHY (CT) SCAN
13.4.2 MRI
13.4.3 ULTRA SOUND
13.4.3.1 ABDOMINAL ULTRASOUND
13.4.3.2 ENDORECTAL ULTRASOUND
13.4.3.3 INTRAOPERATIVE ULTRASOUND
13.4.4 POSITION EMISSION TOMOGRAPHY (PET)
13.4.5 ANGIOGRAPHY
13.4.6 COLONOSCOPY
13.4.7 SIGMOIDOSCOPY
13.4.8 OTHERS
13.5 BIOPSY
13.5.1 ENDOSCOPIC BIOPSY
13.5.2 NEEDLE BIOPSY
13.5.2.1 FINE-NEEDLE ASPIRATION
13.5.2.2 CORE NEEDLE BIOPSY
13.5.3 OTHERS
13.6 OTHERS
14 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 INSTRUMENTS
14.2.1 PATHOLOGY-BASED INSTRUMENTS
14.2.1.1 PCR INSTRUMENTS
14.2.1.2 SLIDE STAINING SYSTEMS
14.2.1.3 TISSUE PROCESSING SYSTEMS
14.2.1.4 CELL PROCESSORS
14.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS
14.2.2 IMAGING INSTRUMENTS AND ACCESSORIES
14.2.2.1 INSTRUMENTS
14.2.2.1.1 ULTRASOUND SYSTEMS
14.2.2.1.2 CT SYSTEMS
14.2.2.1.3 MRI SYSTEMS
14.2.2.1.4 OTHERS
14.2.2.2 ACCESSORIES
14.2.2.2.1 CONTRAST AGENTS
14.2.2.2.1.1 BOWEL PREPARATION KITS
14.2.2.2.1.2 CONTRAST AGENTS
14.2.2.2.2 ENDORECTAL COILS AND PROBES
14.2.2.2.3 RADIOTRACERS
14.2.2.2.4 BOWEL PREPARATION KITS
14.2.3 BIOPSY INSTRUMENTS
14.2.4 OTHERS
14.3 KITS AND REAGENTS
14.3.1 KITS
14.3.1.1 PCR KITS
14.3.1.2 DNA POLYMERASE KITS
14.3.1.3 NUCLEIC ACID ISOLATION KITS
14.3.1.4 OTHERS
14.3.2 REAGENTS
14.3.2.1 FECAL OCCULT BLOOD TEST REAGENTS
14.3.2.2 FECAL IMMUNOCHEMICAL TEST REAGENTS
14.3.2.3 STOOL DNA TEST REAGENTS
14.3.2.4 BLOOD-BASED BIOMARKER TEST REAGENTS
14.3.2.5 TISSUE-BASED BIOMARKER TEST REAGENTS
14.3.2.6 OTHERS
14.3.3 OTHER CONSUMABLES
15 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES
15.1 OVERVIEW
15.2 STAGE III
15.3 STAGE IV
15.4 STAGE II
15.5 STAGE I
15.6 STAGE 0
16 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP
16.1 OVERVIEW
16.2 GERIATRIC
16.3 ADULTS
16.4 PEDIATRIC
17 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE
17.1 OVERVIEW
17.2 ADENOCARCINOMA
17.3 COLORECTAL LYMPHOMA
17.4 GASTROINTESTINAL STROMAL TUMORS
17.5 CARCINOID TUMORS
17.6 LEIOMYOSARCOMAS
17.7 MELANOMAS
17.8 OTHERS
18 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER
18.1 OVERVIEW
18.2 HOSPITALS
18.3 DIAGNOSTIC CENTERS
18.4 CANCER RESEARCH CENTERS
18.5 AMBULATORY SURGICAL CENTERS
18.6 ACADEMIC INSTITUTES
18.7 OTHERS
19 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
19.1 OVERVIEW
19.2 DIRECT TENDER
19.3 RETAIL SALES
19.4 ONLINE SALES
20 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY
20.1 ASIA-PACIFIC
20.1.1 CHINA
20.1.2 INDIA
20.1.3 JAPAN
20.1.4 SOUTH KOREA
20.1.5 THAILAND
20.1.6 SINGAPORE
20.1.7 INDONESIA
20.1.8 MALAYSIA
20.1.9 PHILIPPINES
20.1.10 AUSTRALIA
20.1.11 VIETNAM
20.1.12 REST OF ASIA-PACIFIC
21 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY
21.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
22 SWOT ANALYSIS
23 COMPANY PROFILE
23.1 KONINKLIJKE PHILIPS N.V.
23.1.1 COMPANY SNAPSHOT
23.1.2 REVENUE ANALYSIS
23.1.3 PRODUCT PORTFOLIO
23.1.4 RECENT DEVELOPMENT
23.2 F. HOFFMANN- LA ROCHE LTD
23.2.1 COMPANY SNAPSHOT
23.2.2 REVENUE ANALYSIS
23.2.3 PRODUCT PORTFOLIO
23.2.4 RECENT DEVELOPMENT
23.3 CANON MEDICAL SYSTEMS CORPORATION.
23.3.1 COMPANY SNAPSHOT
23.3.2 REVENUE ANALYSIS
23.3.3 PRODUCT PORTFOLIO
23.3.4 RECENT DEVELOPMENT
23.4 THERMO FISHER SCIENTIFIC INC.
23.4.1 COMPANY SNAPSHOT
23.4.2 REVENUE ANALYSIS
23.4.3 PRODUCT PORTFOLIO
23.4.4 RECENT DEVELOPMENT
23.5 QUEST DIAGNOSTICS INCORPORATED
23.5.1 COMPANY SNAPSHOT
23.5.2 REVENUE ANALYSIS
23.5.3 PRODUCT PORTFOLIO
23.5.4 RECENT DEVELOPMENT
23.6 AGILENT TECHNOLOGIES, INC.
23.6.1 COMPANY SNAPSHOT
23.6.2 REVENUE ANALYSIS
23.6.3 PRODUCT PORTFOLIO
23.6.4 RECENT DEVELOPMENT
23.7 BIOMÉRIEUX SA
23.7.1 COMPANY SNAPSHOT
23.7.2 REVENUE ANALYSIS
23.7.3 PRODUCT PORTFOLIO
23.7.4 RECENT DEVELOPMENT
23.8 BIO-RAD LABORATORIES, INC.
23.8.1 COMPANY SNAPSHOT
23.8.2 REVENUE ANALYSIS
23.8.3 PRODUCT PORTFOLIO
23.8.4 RECENT DEVELOPMENT
23.9 EXACT SCIENCES CORPORATION
23.9.1 COMPANY SNAPSHOT
23.9.2 REVENUE ANALYSIS
23.9.3 PRODUCT PORTFOLIO
23.9.4 RECENT DEVELOPMENT
23.1 FUJIFILM CORPORATION
23.10.1 COMPANY SNAPSHOT
23.10.2 REVENUE ANALYSIS
23.10.3 PRODUCT PORTFOLIO
23.10.4 RECENT DEVELOPMENT
23.11 GE HEALTHCARE.
23.11.1 COMPANY SNAPSHOT
23.11.2 REVENUE ANALYSIS
23.11.3 PRODUCT PORTFOLIO
23.11.4 RECENT DEVELOPMENT
23.12 ILLUMINA, INC.
23.12.1 COMPANY SNAPSHOT
23.12.2 REVENUE ANALYSIS
23.12.3 PRODUCT PORTFOLIO
23.12.4 RECENT DEVELOPMENT
23.13 MYRIAD GENETICS, INC.
23.13.1 COMPANY SNAPSHOT
23.13.2 REVENUE ANALYSIS
23.13.3 PRODUCT PORTFOLIO
23.13.4 RECENT DEVELOPMENT
23.14 MEDTRONIC
23.14.1 COMPANY SNAPSHOT
23.14.2 REVENUE ANALYSIS
23.14.3 PRODUCT PORTFOLIO
23.14.4 RECENT DEVELOPMENT
23.15 NEUSOFT CORPORATION
23.15.1 COMPANY SNAPSHOT
23.15.2 REVENUE ANALYSIS
23.15.3 PRODUCT PORTFOLIO
23.15.4 RECENT DEVELOPMENT
23.16 QIAGEN
23.16.1 COMPANY SNAPSHOT
23.16.2 REVENUE ANALYSIS
23.16.3 PRODUCT PORTFOLIO
23.16.4 RECENT DEVELOPMENT
23.17 SIEMENS HEALTHCARE GMBH
23.17.1 COMPANY SNAPSHOT
23.17.2 REVENUE ANALYSIS
23.17.3 PRODUCT PORTFOLIO
23.17.4 RECENT DEVELOPMENT
23.18 SYSMEX ASIA PACIFIC PTE LTD
23.18.1 COMPANY SNAPSHOT
23.18.2 PRODUCT PORTFOLIO
23.18.3 RECENT DEVELOPMENT
24 QUESTIONNAIRE
25 RELATED REPORTS
表格列表
TABLE 1 COST OF DIAGNOSTIC TEST FOR COLORECTAL CANCER IN INDIA
TABLE 2 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC KITS AND REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 51 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 52 CHINA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 53 CHINA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 54 CHINA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 55 CHINA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 56 CHINA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 57 CHINA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 58 CHINA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 59 CHINA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 60 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 61 CHINA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 CHINA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 63 CHINA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 CHINA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 65 CHINA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 66 CHINA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 67 CHINA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 68 CHINA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 69 CHINA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 71 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 72 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 73 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 74 CHINA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 75 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 76 INDIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 INDIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 78 INDIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 INDIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 80 INDIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 81 INDIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 82 INDIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 83 INDIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 85 INDIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 INDIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 87 INDIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 88 INDIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 89 INDIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 90 INDIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 INDIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 92 INDIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 INDIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 94 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 95 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 96 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 97 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 INDIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 99 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 JAPAN STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 101 JAPAN FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 102 JAPAN BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 103 JAPAN TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 104 JAPAN IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 105 JAPAN ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 106 JAPAN BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 JAPAN NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 108 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 109 JAPAN INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 110 JAPAN PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 111 JAPAN IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 JAPAN INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 113 JAPAN ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 JAPAN CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 115 JAPAN KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 116 JAPAN KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 117 JAPAN REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 118 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 119 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 120 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 121 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 122 JAPAN COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 123 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 124 SOUTH KOREA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 125 SOUTH KOREA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 SOUTH KOREA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 127 SOUTH KOREA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 SOUTH KOREA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 129 SOUTH KOREA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 130 SOUTH KOREA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 131 SOUTH KOREA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 132 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 SOUTH KOREA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 134 SOUTH KOREA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 135 SOUTH KOREA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 136 SOUTH KOREA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 137 SOUTH KOREA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 138 SOUTH KOREA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 139 SOUTH KOREA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 SOUTH KOREA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 141 SOUTH KOREA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 143 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 144 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 145 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 146 SOUTH KOREA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 147 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 148 THAILAND STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 THAILAND FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 150 THAILAND BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 151 THAILAND TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 152 THAILAND IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 153 THAILAND ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 154 THAILAND BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 155 THAILAND NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 157 THAILAND INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 THAILAND PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 159 THAILAND IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 160 THAILAND INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 161 THAILAND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 162 THAILAND CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 163 THAILAND KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 164 THAILAND KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 THAILAND REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 166 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 167 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 168 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 169 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 170 THAILAND COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 171 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 SINGAPORE STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 173 SINGAPORE FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 174 SINGAPORE BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 175 SINGAPORE TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 176 SINGAPORE IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 SINGAPORE ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 178 SINGAPORE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 179 SINGAPORE NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 180 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 181 SINGAPORE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 182 SINGAPORE PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 183 SINGAPORE IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 SINGAPORE INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 185 SINGAPORE ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 SINGAPORE CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 187 SINGAPORE KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 188 SINGAPORE KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 189 SINGAPORE REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 190 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 191 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 192 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 194 SINGAPORE COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 195 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 196 INDONESIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 197 INDONESIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 INDONESIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 199 INDONESIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 INDONESIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 201 INDONESIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 202 INDONESIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 203 INDONESIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 204 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 INDONESIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 206 INDONESIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 INDONESIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 208 INDONESIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 209 INDONESIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 210 INDONESIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 211 INDONESIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 212 INDONESIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 213 INDONESIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 214 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 215 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 216 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 217 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 INDONESIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 219 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 220 MALAYSIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 MALAYSIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 222 MALAYSIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 223 MALAYSIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 224 MALAYSIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 225 MALAYSIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 226 MALAYSIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 227 MALAYSIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 228 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 229 MALAYSIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 230 MALAYSIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 231 MALAYSIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 232 MALAYSIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 233 MALAYSIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 234 MALAYSIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 MALAYSIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 236 MALAYSIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 MALAYSIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 238 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 239 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 240 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 241 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 242 MALAYSIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 243 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 244 PHILIPPINES STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 245 PHILIPPINES FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 246 PHILIPPINES BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 247 PHILIPPINES TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 248 PHILIPPINES IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 249 PHILIPPINES ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 250 PHILIPPINES BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 PHILIPPINES NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 252 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 PHILIPPINES INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 254 PHILIPPINES PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 255 PHILIPPINES IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 256 PHILIPPINES INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 257 PHILIPPINES ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 258 PHILIPPINES CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 259 PHILIPPINES KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 260 PHILIPPINES KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 261 PHILIPPINES REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 262 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 263 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 264 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 265 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 266 PHILIPPINES COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 267 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 268 AUSTRALIA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 269 AUSTRALIA FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 270 AUSTRALIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 271 AUSTRALIA TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 272 AUSTRALIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 273 AUSTRALIA ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 274 AUSTRALIA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 275 AUSTRALIA NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 276 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 277 AUSTRALIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 278 AUSTRALIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 279 AUSTRALIA IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 280 AUSTRALIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 281 AUSTRALIA ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 282 AUSTRALIA CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 283 AUSTRALIA KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 284 AUSTRALIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 285 AUSTRALIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 286 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 287 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 288 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 289 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 290 AUSTRALIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 291 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 292 VIETNAM STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 293 VIETNAM FECAL OCCULT BLOOD TEST (FOBT) IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 294 VIETNAM BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 295 VIETNAM TUMOR MARKER TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 296 VIETNAM IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 297 VIETNAM ULTRA SOUND IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 298 VIETNAM BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 299 VIETNAM NEEDLE BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
TABLE 300 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 301 VIETNAM INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 302 VIETNAM PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 303 VIETNAM IMAGING INSTRUMENTS AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 304 VIETNAM INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 305 VIETNAM ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 306 VIETNAM CONTRAST AGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 307 VIETNAM KITS AND REGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 308 VIETNAM KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 309 VIETNAM REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)
TABLE 310 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD THOUSAND)
TABLE 311 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD THOUSAND)
TABLE 312 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD THOUSAND)
TABLE 313 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 314 VIETNAM COLORECTAL CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 315 REST OF ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)
图片列表
FIGURE 1 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: MARKET END-USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT COLORECTAL CANCER IS EXPECTED TO DRIVE THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE STOOL EXAMINATION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET
FIGURE 14 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022
FIGURE 15 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD THOUSAND)
FIGURE 16 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030)
FIGURE 17 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022
FIGURE 19 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND)
FIGURE 20 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 21 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022
FIGURE 23 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD THOUSAND)
FIGURE 24 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030)
FIGURE 25 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022
FIGURE 27 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD THOUSAND)
FIGURE 28 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030)
FIGURE 29 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022
FIGURE 31 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD THOUSAND)
FIGURE 32 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030)
FIGURE 33 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2022
FIGURE 35 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 36 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 39 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 40 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 41 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022)
FIGURE 43 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022)
FIGURE 44 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE (2023-2030)
FIGURE 47 ASIA-PACIFIC COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
